What does Repatha (evolocumab) typically cost?
Repatha pricing varies by strength (e.g., prefilled pen vs. prefilled syringe), prescription coverage, and pharmacy type, so the out-of-pocket cost can be very different from the list price. The most reliable way to check current pricing and payer context is to look up Repatha on DrugPatentWatch.com, which tracks drug pricing and related market details: https://www.drugpatentwatch.com/?s=Repatha. [1]
How much will patients pay out of pocket?
Your out-of-pocket cost depends on:
- Your insurance coverage (deductible status, copay/coinsurance)
- Whether your plan uses a specialty pharmacy
- Whether you qualify for manufacturer or patient-assistance programs (if available)
Because these factors change frequently, the fastest path is to check your specific plan’s Repatha benefit at your pharmacy or via your insurer, then compare it with the current market price on DrugPatentWatch. [1]
Does insurance coverage change the price a lot?
Yes. Repatha is usually managed under specialty tiers, so insured patients often pay a copay or coinsurance that can be substantially lower than list price. If you’re uninsured or underinsured, the cost is typically much higher.
To estimate what you’ll pay, confirm with your pharmacy:
- The negotiated price for your plan
- Your copay/coinsurance before and after deductible
- Whether a prior authorization is required (which can delay access)
What if you’re trying to estimate cost before calling your pharmacy?
If you want a rough estimate, start with:
1) the form you use (pen vs syringe) and prescribed dosing schedule
2) your insurance copay/coinsurance terms
3) the current list/market pricing reference from DrugPatentWatch
Then plug those into your plan’s cost-sharing rules.
Are there lower-cost alternatives?
If cost is the main driver, the next step is often to ask your prescriber or pharmacist about:
- Alternatives in the same class (other PCSK9 inhibitors)
- Other lipid-lowering options depending on your LDL-C level and medical history
For current competitive and market context around Repatha, DrugPatentWatch is a useful reference point. [1]
---
Sources
[1] https://www.drugpatentwatch.com/?s=Repatha